Vodafone Idea Monitoring Report for Quarter Ended September 30, 2025

Vodafone Idea Limited has released its Monitoring Agency Report for the quarter ended September 30, 2025. The report, issued by CARE Ratings Limited, pertains to the utilization of proceeds raised through the Further Public Offer (FPO). It confirms that FPO proceeds have been utilized as per the objectives outlined in the offer document, with reallocations approved by the Board.

FPO Proceeds Utilization

The Monitoring Agency Report for the quarter ended September 30, 2025, confirms that Vodafone Idea has utilized the proceeds from its Further Public Offer (FPO) in line with the objectives outlined in the offer document. CARE Ratings Limited issued the report.

Key Highlights from the Report

All proceeds from the FPO have been utilized appropriately for the objectives mentioned in the offer document. A reallocation of proceeds was implemented via a resolution passed by the Board of Directors on May 30, 2025.

Detailed Financial Breakdown

Of the ₹17,614.20 crore net proceeds, ₹10,492.00 crore was allocated to purchase equipment for network expansion. A further ₹4,433.32 crore was for deferred payments to the DoT and GST. General corporate purposes accounted for ₹2,688.88 crore. Revisions from the original allocation, amounting to approximately ₹2,258 crore, were approved by the Board. The monitoring agency has made note of no material deviations from expenditures disclosed in the offer document.

Deployment of Unutilized Proceeds

As of September 30, 2025, the unutilized proceeds, totaling ₹2,715.76 crore, were largely deployed in fixed deposits with various financial institutions like IDBI, SBI and ICICI with maturity dates ranging from October 2025 to February 2026 and average returns ranging from 3.00% to 7.56%. A portion was allocated to cash balance.

Source: BSE

InvestyWise News
InvestyWise News
Covers market-moving news with speed and precision, delivering sharp insights to help readers stay ahead in the fast-paced world of stocks.

Latest articles

Related articles

Leave a reply

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!